113 related articles for article (PubMed ID: 6293991)
1. Experimental myasthenia gravis: a model of receptor disease.
Takamori M; Kasai M
Int J Neurol; 1980; 14(1):47-60. PubMed ID: 6293991
[No Abstract] [Full Text] [Related]
2. The immunopathology of myasthenia gravis.
Engel AG
Int J Neurol; 1980; 14(1):35-46. PubMed ID: 6293990
[No Abstract] [Full Text] [Related]
3. Experimental autoimmune myasthenia gravis: the rabbit as an animal model.
Eldefrawi ME
Fed Proc; 1978 Dec; 37(14):2823-7. PubMed ID: 720635
[TBL] [Abstract][Full Text] [Related]
4. A myasthenia gravis plasma immunoglobulin reduces miniature endplate potentials at human endplates in vitro.
Burges J; Wray DW; Pizzighella S; Hall Z; Vincent A
Muscle Nerve; 1990 May; 13(5):407-13. PubMed ID: 2345558
[TBL] [Abstract][Full Text] [Related]
5. Effects of antibodies to Torpedo acetylcholine receptor on the acetylcholine receptor--ionic channel complex of Torpedo electroplax and rabbit intercostal muscle.
Eldefrawi ME; Copio DS; Hudson CS; Rash J; Mansour NA; Eldefrawi AT; Albuguergue EX
Exp Neurol; 1979 May; 64(2):428-44. PubMed ID: 428517
[No Abstract] [Full Text] [Related]
6. Myasthenia gravis and acetylcholine receptor: autoimmunity and steroid effects.
Abramsky O
Int J Neurol; 1980; 14(1):25-34. PubMed ID: 6293989
[No Abstract] [Full Text] [Related]
7. Structure-function correlations in myasthenia gravis and a new myasthenic syndrome.
Engel AG; Lambert EH
Electroencephalogr Clin Neurophysiol Suppl; 1978; (34):469-77. PubMed ID: 220007
[TBL] [Abstract][Full Text] [Related]
8. The immunopathological basis of acetylcholine receptor deficiency in myasthenia gravis.
Engel AG
Prog Brain Res; 1979; 49():423-34. PubMed ID: 515440
[No Abstract] [Full Text] [Related]
9. [Immunologic studies of the role of cholinergic receptors in the pathogenesis of myasthenia gravis].
Członkowski A; Członkowska A
Neurol Neurochir Pol; 1978; 12(5):633-7. PubMed ID: 214726
[No Abstract] [Full Text] [Related]
10. [Experimental rabbit model of myasthenia gravis produced with acetylcholine receptor of nicotinic type from the "generating organ" of electric ray (author's transl)].
Tu LH
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1981 Feb; 14(1):16-8. PubMed ID: 7307781
[No Abstract] [Full Text] [Related]
11. Experimental myasthenia: lack of correlation between the autoantibody titer and the reduction of acetylcholine-controlled ionic channels measured at functioning endplates.
Hohlfeld R; Sterz R; Kalies I; Wekerle H; Peper K
Muscle Nerve; 1983 Feb; 6(2):160-3. PubMed ID: 6304508
[No Abstract] [Full Text] [Related]
12. Electrophysiological studies of thymectomized and nonthymectomized acetylcholine receptor-immunized animal models of myasthenia gravis.
Niemi WD; Nastuk WL; Chang HW; Penn AS; Rosenberry TL
Exp Neurol; 1979 Jan; 63(1):1-27. PubMed ID: 223859
[No Abstract] [Full Text] [Related]
13. Postsynapic membrane of Torpedo electroplax: acetylcholine receptor localization and its use as a tool in the study of cellular immuninty in myasthenia gravis.
Conti-Tronconi B; Morgutti M; Gotti C; Clementi F
Adv Cytopharmacol; 1979; 3():255-67. PubMed ID: 382788
[No Abstract] [Full Text] [Related]
14. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
[TBL] [Abstract][Full Text] [Related]
15. Myasthenia gravis animal model: quantitative analysis of the efficiency of pre- and postjunctional regions of intercostal muscles in rabbits immunized with Torpedo acetylcholine receptor.
Albuquerque EX; Eldefrawi AT; Oliveira AC; Copio DS; Eldefrawi ME
Exp Neurol; 1979 Oct; 66(1):109-22. PubMed ID: 225189
[No Abstract] [Full Text] [Related]
16. Autoimmunity to cell membrane receptors.
De Baets MH; van Breda Vriesman PJ
Surv Synth Pathol Res; 1985; 4(3):185-215. PubMed ID: 3008292
[No Abstract] [Full Text] [Related]
17. Neuromuscular transmission in neonatal mice injected with serum globulin of myasthenia gravis patients.
Pagala MK; Tada S; Namba T; Grob D
Neurology; 1982 Jan; 32(1):12-7. PubMed ID: 6275304
[TBL] [Abstract][Full Text] [Related]
18. Myasthenia gravis (first of two parts).
Drachman DB
N Engl J Med; 1978 Jan; 298(3):136-42. PubMed ID: 201840
[No Abstract] [Full Text] [Related]
19. Experimental myasthenia gravis is inhibited by receptor-antireceptor complexes.
Barkas T; Simpson JA
J Clin Lab Immunol; 1982 Apr; 7(3):223-7. PubMed ID: 7097749
[TBL] [Abstract][Full Text] [Related]
20. Immunopathologic events at the endplate in myasthenia gravis.
Ashizawa T; Appel SH
Springer Semin Immunopathol; 1985; 8(3):177-96. PubMed ID: 2413561
[No Abstract] [Full Text] [Related]
[Next] [New Search]
